Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by Ramesh Ramalingam  – India, 2018-04-13 10:52 (1292 d 19:05 ago) – Posting: # 18679
Views: 2,304

Dear All,

Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT (oral Dispersible Tablet) BE study. Could any one please suggest the drug administration procedure for oral Dispersible Tablet in bioequivalence study (If product specific BE study recommendation not issued).

:confused:

Regards,
Ramesh.R:

Complete thread:

Activity
 Admin contact
21,758 posts in 4,550 threads, 1,544 registered users;
online 8 (0 registered, 8 guests [including 4 identified bots]).
Forum time: Wednesday 05:57 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5